Literature DB >> 28071857

Risk of hypertensive disorders in pregnancy following assisted reproductive technology: overview and meta-analysis.

Costas Thomopoulos1, George Salamalekis2, Konstantinos Kintis3, Iliana Andrianopoulou1, Helena Michalopoulou1, George Skalis1, Stefanos Archontakis1, Ourania Argyri1, Costas Tsioufis3, Thomas K Makris1, Emmanuel Salamalekis2.   

Abstract

The extent of the increased risk of pregnancy hypertensive disorders following assisted reproductive technology (ART) was investigated. PubMed and the Cochrane Collaboration Library were used as data sources to identify and select longitudinal cohorts comparing pregnancies following ART with spontaneously conceived pregnancies, between 1978 and June 2016. Risk ratios and 95% confidence intervals (CIs) of three outcomes, ie, gestational hypertension (GH), preeclampsia (PE), and their sum (PHD), were calculated. Stratification of results by gestation order (singletons and nonsingletons) was pursued, but a separate "all orders" mixed stratification was considered. Sixty-six longitudinal studies (7 038 029 pregnancies; 203 375 following any ART) were eligible. All outcomes independent of gestation order ("all orders") were increased following any invasive ART: GH (+79% [95% CI, 24%-157%]) and PE (+75% [95% CI, 50%-103%]) to a greater extent, with smaller increases in PHD (+54% [95% CI, 39%-70%]). The risk of PHD following ART steadily increased independent of gestation order. ©2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  assisted pregnancy; gestational hypertension; infertility; preeclampsia; pregnancy-induced hypertension

Mesh:

Year:  2016        PMID: 28071857      PMCID: PMC8031300          DOI: 10.1111/jch.12945

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  24 in total

Review 1.  Assisted reproductive technology and the risk of pregnancy-related complications and adverse pregnancy outcomes in singleton pregnancies: a meta-analysis of cohort studies.

Authors:  Jiabi Qin; Xiaoying Liu; Xiaoqi Sheng; Hua Wang; Shiyou Gao
Journal:  Fertil Steril       Date:  2015-10-09       Impact factor: 7.329

2.  Oocyte donation: a risk factor for pregnancy-induced hypertension: a meta-analysis and case series.

Authors:  Ulrich Pecks; Nicolai Maass; Joseph Neulen
Journal:  Dtsch Arztebl Int       Date:  2011-01-21       Impact factor: 5.594

3.  The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement from the ISSHP.

Authors:  A L Tranquilli; G Dekker; L Magee; J Roberts; B M Sibai; W Steyn; G G Zeeman; M A Brown
Journal:  Pregnancy Hypertens       Date:  2014-02-15       Impact factor: 2.899

Review 4.  Redefining preeclampsia using placenta-derived biomarkers.

Authors:  Anne Cathrine Staff; Samantha J Benton; Peter von Dadelszen; James M Roberts; Robert N Taylor; Robert W Powers; D Stephen Charnock-Jones; Christopher W G Redman
Journal:  Hypertension       Date:  2013-03-04       Impact factor: 10.190

Review 5.  Obstetric and perinatal outcomes in singleton pregnancies resulting from IVF/ICSI: a systematic review and meta-analysis.

Authors:  Shilpi Pandey; Ashalatha Shetty; Mark Hamilton; Siladitya Bhattacharya; Abha Maheshwari
Journal:  Hum Reprod Update       Date:  2012-05-19       Impact factor: 15.610

6.  Cumulative live-birth rates after in vitro fertilization.

Authors:  Beth A Malizia; Michele R Hacker; Alan S Penzias
Journal:  N Engl J Med       Date:  2009-01-15       Impact factor: 91.245

7.  ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists.

Authors: 
Journal:  Int J Gynaecol Obstet       Date:  2002-04       Impact factor: 3.561

8.  Comparison of obstetric outcomes in recipients of donor oocytes vs. women of advanced maternal age with autologous oocytes.

Authors:  Melinda B Henne; Mallory Zhang; Sylvie Paroski; Bhagyashree Kelshikar; Lynn M Westphal
Journal:  J Reprod Med       Date:  2007-07       Impact factor: 0.142

9.  A prospective study of maternal, fetal and neonatal deaths in low- and middle-income countries.

Authors:  Sarah Saleem; Elizabeth M McClure; Shivaprasad S Goudar; Archana Patel; Fabian Esamai; Ana Garces; Elwyn Chomba; Fernando Althabe; Janet Moore; Bhalachandra Kodkany; Omrana Pasha; Jose Belizan; Albert Mayansyan; Richard J Derman; Patricia L Hibberd; Edward A Liechty; Nancy F Krebs; K Michael Hambidge; Pierre Buekens; Waldemar A Carlo; Linda L Wright; Marion Koso-Thomas; Alan H Jobe; Robert L Goldenberg
Journal:  Bull World Health Organ       Date:  2014-06-05       Impact factor: 9.408

10.  RETIRED: Pregnancy outcomes after assisted reproductive technology.

Authors:  Victoria M Allen; R Douglas Wilson; Anthony Cheung
Journal:  J Obstet Gynaecol Can       Date:  2006-03
View more
  11 in total

1.  Hypertensive disorders of pregnancy and infertility treatment: a population-based survey among United States women.

Authors:  Brent C Monseur; Jerrine R Morris; Heather S Hipp; Vincenzo Berghella
Journal:  J Assist Reprod Genet       Date:  2019-05-27       Impact factor: 3.412

2.  Assisted reproductive technologies induce temporally specific placental defects and the preeclampsia risk marker sFLT1 in mouse.

Authors:  Lisa A Vrooman; Eric A Rhon-Calderon; Olivia Y Chao; Duy K Nguyen; Laren Narapareddy; Asha K Dahiya; Mary E Putt; Richard M Schultz; Marisa S Bartolomei
Journal:  Development       Date:  2020-05-29       Impact factor: 6.868

3.  Potential influence of the corpus luteum on circulating reproductive and volume regulatory hormones, angiogenic and immunoregulatory factors in pregnant women.

Authors:  Kirk P Conrad; Georgia M Graham; Yueh-Yun Chi; Xiaoman Zhai; Minjie Li; R Stan Williams; Alice Rhoton-Vlasak; Mark S Segal; Charles E Wood; Maureen Keller-Wood
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-08-13       Impact factor: 4.310

4.  Risk of hypertensive disorders in pregnancy following assisted reproductive technology: overview and meta-analysis.

Authors:  Costas Thomopoulos; George Salamalekis; Konstantinos Kintis; Iliana Andrianopoulou; Helena Michalopoulou; George Skalis; Stefanos Archontakis; Ourania Argyri; Costas Tsioufis; Thomas K Makris; Emmanuel Salamalekis
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-11-07       Impact factor: 3.738

5.  Association between hypertensive disorders of pregnancy and the risk of postpartum hypertension: a cohort study in women with gestational diabetes.

Authors:  L Wang; J Leng; H Liu; S Zhang; J Wang; W Li; W Li; N Li; T Zhang; A A Baccarelli; L Hou; X Yang; Z Yu; G Hu
Journal:  J Hum Hypertens       Date:  2017-06-29       Impact factor: 3.012

6.  Immunological Tolerance, Pregnancy, and Preeclampsia: The Roles of Semen Microbes and the Father.

Authors:  Louise C Kenny; Douglas B Kell
Journal:  Front Med (Lausanne)       Date:  2018-01-04

7.  Maternal-Perinatal Variables in Patients with Severe Preeclampsia Who Develop Acute Kidney Injury.

Authors:  Patrocinio Rodríguez-Benitez; Irene Aracil Moreno; Cristina Oliver Barrecheguren; Yolanda Cuñarro López; Fátima Yllana; Pilar Pintado Recarte; Coral Bravo Arribas; Melchor Álvarez-Mon; Miguel A Ortega; Juan A De Leon-Luis
Journal:  J Clin Med       Date:  2021-11-29       Impact factor: 4.241

8.  Maternal Vascular Health in Pregnancy and Postpartum After Assisted Reproduction.

Authors:  Frauke von Versen-Höynck; Sebastian Häckl; Elif Seda Selamet Tierney; Kirk P Conrad; Valerie L Baker; Virginia D Winn
Journal:  Hypertension       Date:  2019-12-16       Impact factor: 10.190

Review 9.  Hypertension in Women Across the Lifespan.

Authors:  Lama Ghazi; Natalie A Bello
Journal:  Curr Atheroscler Rep       Date:  2021-06-19       Impact factor: 5.967

10.  Temporal Trends in Pregnancy-Associated Stroke and Its Outcomes Among Women With Hypertensive Disorders of Pregnancy.

Authors:  Pensée Wu; Kelvin P Jordan; Carolyn A Chew-Graham; Thais Coutinho; Gina P Lundberg; Ki E Park; Lucy C Chappell; Phyo K Myint; Angela H E M Maas; Mamas A Mamas
Journal:  J Am Heart Assoc       Date:  2020-07-29       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.